Inactive

Brand Name Required: Illumina MiSeq System The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Illumina, Inc for the Illumina MiSeq system.... Brand Name Required: Illumina MiSeq System The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Illumina, Inc for the Illumina MiSeq system. Illumina MiSeq system, and its installation can only be purchased through the brand-name company. This system and its output have been validated through the Polio and Picornavirus branch to generate next generation data used extensively for the surveillance of poliovirus and picornavirus through molecular epidemiology; other system has not been validated and therefore cannot archive the same result. Moreover, the existing analysis pipeline is tailored to handle the data generated by the MiSeq systems. Unlike the MiSeq system, other platforms have not been validated and therefore cannot be sure to archive the same result. Also, the data needs to be generated with consistency; producing data using another platform will be unfavorable to data analysis. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1).. Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at Qrz9@cdc.gov by COB 28 June, 2022.